On January 23, 2024, Better Therapeutics, Inc. closed the transaction. The company issued 1,471,453 shares at an issue price of $0.1699 per share for the gross proceeds of $249,999.8647 pursuant to Regulation D and included participation from single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0109 USD | -5.22% | +9.00% | -94.41% |
03-21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
03-20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.41% | 594K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BTTX Stock
- News Better Therapeutics, Inc.
- Better Therapeutics, Inc. announced that it has received $0.25 million in funding